Blog - Page 3277 of 5757

TuesdayMay 15, 2012 9:44 am

Maxygen, Inc. (MAXY) to Receive $30 Million from Bayer Healthcare for Hemophilia Treatment Product Candidate

Maxygen announced that it will receive a $30.0 million payment from Bayer HealthCare LLC in connection with Bayer's clinical development of a recombinant factor VIIa product candidate for the treatment of hemophilia. Maxygen sold the recombinant factor VIIa product candidate (previously designated by Maxygen as MAXY-VII) to Bayer in July 2008 for an upfront cash payment of $90.0 million. The purchase included all of its other hematology assets. As of Monday, the additional $30.0 million contingent payment was based on the product candidate's further development by Bayer and was also subject to the satisfaction of certain patent related conditions -…

TuesdayMay 15, 2012 9:11 am

International Stem Cell Corp. (ISCO) Scientists to Attend Gene and Cell Therapy Meeting in Philadelphia and Present Pre-Clinical Research Results

International Stem Cell Corp. this morning announced that several of its leading scientists will be presenting experimental results from three of ISCO’s pre-clinical therapeutic programs at the 15th Annual Meeting of American Society of Gene and Cell Therapy, in Philadelphia at 3:30 p.m. on Thursday, May 17th. Firstly, the application of A9 dopaminergic neurons derived from human parthenogenetic stem cells (hpSC) for the treatment of Parkinson’s disease. Demonstrating functional dopaminergic neurons in vivo represents an important milestone towards the goal of creating well characterized populations of cells that could be used to develop a treatment for Parkinson’s. Secondly, the differentiation…

MondayMay 14, 2012 4:58 pm

VolitionRX Ltd. (VNRX) Completes $1M Financing to Begin Clinical Trials of Blood-based Diagnostics Tests

VolitionRX, a life sciences company focused on developing blood-based diagnostic tests, today announced it has raised $1.0 million through the closure of a private placement of 582,510 shares at $1.75 per share. The company will use the proceeds in part to fund clinical trials of VolitionRX's first NuQ™ test kits. The funds are allocated to initial clinical trials of VolitionRX's NuQ kits, blood-based diagnostic tests based on VolitionRX's Nucleosomics technology; as well as for ongoing capital needs. "We're delighted that we have raised over $1 million, which will allow us to begin clinical trials of our tests, both in-house and…

MondayMay 14, 2012 3:45 pm

Data Storage Corp. (DTST) Completes Phase I, II of Waltham Data Center Facility

Data Storage, a provider of cloud storage and cloud computing focused on data protection and business continuity solutions, today announced it has completed the first two phases of its three-phased expansion plan for its Waltham data center facility. The company says the phase 1 and 2 completions more than triple the company’s existing footprint with the additional installation of IBM's iSeries High Availability and Disaster Recovery server hardware and the new IBM iSeries Hosted Cloud solution. In addition to the added High Availability and Disaster Recovery capacity upgrades, the expansion also greatly increases the company's cloud-based offsite storage and data…

MondayMay 14, 2012 3:34 pm

GlobalWise Investments, Inc. (GWIV) Sees Partner Success Driving Triple-Digit Growth

GlobalWise Investments, through its wholly-owned subsidiary Intellinetics, provides cloud-based ECM (Enterprise Content Management) solutions to both public and private sectors in the U.S., and is now beginning to expand outside the country. In late April, the company announced a channel partnership with SOIN Integrales, a partnership that expands GlobalWise sales opportunities into Latin America. It’s just one of many partnerships that GlobalWise believes will result in triple-digit growth for the next several years: • May 2, 2012 – Channel Sales Partnership announced with eVero Corporation, opening up opportunities in the health and human services industries • April 17, 2012 –…

MondayMay 14, 2012 10:29 am

Gold Drops to 4 ½ Month Low on Euro Worries, Risk Off Trade

The risk off trade (sell everything) continued to extend to gold today as worries over the European debt crisis mounted. Continued political gridlock in Greece and problems in the Spanish banking system fed the doubts about the continent's economic viability and that of its currency, the euro, in its current state. Gold moved higher earlier this year, along with other riskier assets like stocks, as investors thought the euro crisis was receding. Spot gold hit a 4 ½ month low on Monday, dipping down to $1559.81 an ounce, its lowest point since December 2011. Gold closed in New York on…

MondayMay 14, 2012 10:28 am

American Standard Energy Corp. (ASEN) Reports Financial Results for First Quarter of 2012

American Standard Energy reported a sharp year-over-year increase in oil and gas revenues in the first quarter of 2012. The company also confirmed progress on the exploration and development of onshore oil and gas assets. American Standard Energy reported oil and gas sales of $5 million in the quarter ending March 31, 2012, up 109% from the $2.4 million recorded in the corresponding quarter of 2011. The company said that the increase was due to many factors, including higher production and higher realized prices for crude oil. American Standard Energy reported production of 68,137 barrels of oil equivalent (BOE) in…

MondayMay 14, 2012 10:17 am

International Stem Cell Corp. (ISCO) Video Chart for Monday, May 14, 2012

ISCO has formed a triple bottom pattern with support at 40 cents. There is more support down at 34 cents, but the 40 cent mark has produced two bounces in excess of 50 percent (to $0.68 and $0.65) in the last five months. Technical traders will be watching closely for the pattern to repeat. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts: International Stem Cell Corp. Message Board

MondayMay 14, 2012 8:57 am

Cover-All Technologies, Inc. (COVR) NexGen Business Intelligence Solution Featured in Recent Novarica Report

Cover-All Technologies, a Delaware corporation and leading developer of sophisticated software solutions for the property and casualty insurance industry, announced its business intelligence (BI) solution, NexGen Business Intelligence, has been included in a Novarica report profiling insurance BI solutions. Novarica is a research and advisory firm focused on insurance technology strategy. The report, “Business Intelligence Solutions for U.S. Insurers 2012 (Q1),” profiles 19 vendors that currently offer BI solutions. The report describes the growing importance of BI and key areas of use by property/casualty insurance companies. According to Martina Conlon, principal for Novarica’s insurance team and author of the report,…

MondayMay 14, 2012 8:50 am

Quasar Aerospace Industries, Inc. (QASP) Announces Major Reduction in Authorized Shares

Quasar Aerospace Industries just announced that after a meeting of the majority of shareholders and the Board of Directors, the company has reduced the total number of shares authorized to four hundred and seventy-five million (475,000,000). According to the press release issued this morning, Quasar Aerospace felt that the share reduction was prudent at this time. The company stated that it will continue to look to align its share structure and capitalization more appropriately; including the conversion terms of the preferred shares. Quasar Aerospace also reminded the investment company of its announced conference call scheduled for Wednesday May 16, 2012,…

Site Search

Company Search